Also known as: Saquinavir Methanesulfonate; Invirase Mesylate
Saquinavir Mesylate is the methanesulfonate salt form of Saquinavir, offering improved solubility and bioavailability profiles compared to the free base. Mediocon Inc supplies pharmaceutical-grade Saquinavir Mesylate conforming to IP / BP / EP / USP specifications from our GMP-certified facility in Aurangabad, Maharashtra, India.
The mesylate salt enhances crystallinity and handling properties suitable for solid oral dosage forms. It retains the protease inhibitory activity of the parent compound against HIV-1 and HIV-2.
Key Features
Applications
Why Choose Mediocon
| Parameter | Specification |
|---|---|
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Mfg Date | MAR 2025 |
| Exp Date | FEB 2030 |
| Packing | 25 kg HDPE drums / as per requirement |